LivaNova (LIVN) Competitors

Penumbra (NYSE:PEN) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

Do insiders & institutionals believe in PEN or LIVN?

88.9% of Penumbra shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 4.2% of Penumbra shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the media prefer PEN or LIVN?

In the previous week, Penumbra had 13 more articles in the media than LivaNova. MarketBeat recorded 14 mentions for Penumbra and 1 mentions for LivaNova. LivaNova's average media sentiment score of 1.13 beat Penumbra's score of 0.25 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, PEN or LIVN?

LivaNova has lower revenue, but higher earnings than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.28B	7.60	$14.01M	$3.76	66.31
LivaNova	$1.25B	2.34	$63.23M	-$3.89	-13.81

Do analysts rate PEN or LIVN?

Penumbra currently has a consensus target price of $302.81, suggesting a potential upside of 21.45%. LivaNova has a consensus target price of $59.71, suggesting a potential upside of 11.14%. Given Penumbra's stronger consensus rating and higher probable upside, analysts plainly believe Penumbra is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.89
LivaNova	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has more volatility and risk, PEN or LIVN?

Penumbra has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500.

Is PEN or LIVN more profitable?

Penumbra has a net margin of 11.54% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.54%	11.55%	8.76%
LivaNova	-16.13%	14.57%	6.91%

Summary

Penumbra beats LivaNova on 12 of the 17 factors compared between the two stocks.